Markets:

Overview

News

Currencies

International

Treasuries

vTv Therapeutics Inc. - Class A Common Stock (NQ:VTVT)

26.21 +0.66 (+2.60%)

Delayed Quote Updated: 2:11 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about vTv Therapeutics Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >

vTv Therapeutics Highlights Cadisegliatin’s Phase III Push to Tackle Type 1 Hypoglycemia ↗

October 20, 2026

vTv Therapeutics (NASDAQ:VTVT) used a virtual key opinion leader event to outline the continuing burden of hypoglycemia in type 1 diabetes, present patient and physician market-research findings, and...

Via MarketBeat

vTv Therapeutics Inc. (NASDAQ:VTVT) Reports Massive Q1 Earnings Beat, But Stock Dips on "Sell the News" Reaction ↗

May 13, 2026

Via Chartmill

Topics Earnings

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 06, 2025

Via Benzinga

Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket ↗

October 06, 2025

Via Benzinga

VTVT Stock Earnings: vTv Therapeutics Reported Results for Q2 2024 ↗

August 09, 2024

vTv Therapeutics just reported results for the second quarter of 2024.

Via InvestorPlace

VTVT Stock Earnings: vTv Therapeutics Reported Results for Q1 2024 ↗

May 09, 2024

vTv Therapeutics just reported results for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 06, 2025

Via Benzinga

VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress ↗

August 12, 2025

vTv Therapeutics reports Q2 2025 loss of $0.92 per share, missing estimates. Revenue at $0 as expected. Shares rise slightly amid focus on Phase 3 diabetes trial progress.

Via Chartmill

This Couchbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

April 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 19, 2025

Via Benzinga

FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges ↗

March 17, 2025

vTv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month timeline to accelerate key studies.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 17, 2025

Via Benzinga

Dow Edges Lower; Ventyx Biosciences Shares Plummet ↗

July 29, 2024

Via Benzinga

Topics Stocks

Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 29, 2024

Via Benzinga

Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump ↗

July 29, 2024

Via Benzinga

FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks ↗

July 29, 2024

vTv Therapeutics faces a setback as the FDA places a clinical hold on its cadisegliatin program, impacting the CATT1 Phase 3 trial for type 1 diabetes.

Via Benzinga

Nasdaq Gains 1%; McDonald's Posts Downbeat Results ↗

July 29, 2024

Via Benzinga

Why Is LuxUrban Hotels (LUXH) Stock Down 12% Today? ↗

July 29, 2024

LuxUrban Hotels stock is down on Monday after the company priced a public offering of LUXH shares below its prior closing price.

Via InvestorPlace

Why Is vTv Therapeutics (VTVT) Stock Down 46% Today? ↗

July 29, 2024

VTv Therapeutics stock is falling on Monday as VTVT investors react to the company's cadisegliatin clinical program being put on hold.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

July 29, 2024

Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!

Via InvestorPlace

Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗

July 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 05, 2024

Via Benzinga

The Top 3 Healthcare Stocks to Buy on Weakness in 2024 ↗

March 04, 2024

Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy.

Via InvestorPlace

S&P 500 Edges Lower; ADT Posts Upbeat Earnings ↗

February 28, 2024

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The...

Via Benzinga

Topics Stocks

Why Is Diabetes Focused vTv Therapeutics Stock Trading Higher Today? ↗

February 28, 2024

vTv Therapeutics stock surge, fueled by a $51M private placement. Learn about their clinical-stage biopharmaceutical focus on cadisegliatin for type 1 diabetes. Stock up 111.8% at $18.

Via Benzinga

TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares? ↗

February 28, 2024

The company reported in-line sales for the fourth quarter, but shares soared by double digits.

Via Investor's Business Daily

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 28, 2024

Via Benzinga

Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels ↗

February 28, 2024

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow traded down 0.19% to 38,899.92 while the NASDAQ fell 0.31% to 15,985.25. The...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.